COVID-19 vaccines - the race to the front
This one got you clicking - Pfizer announcing its COVID-19 vaccine timeline mid-way through last month.
The pharma giant said, at that juncture, that it ‘may know’ whether or not the vaccine candidate was effective by the end of October, with safety data expected in the third week of November. Pfizer said then it would apply for an EUA ‘soon after’ this safety data is available.
To great global fervour Pfizer actually only revealed on Monday [November 9] that Phase 3 interim analysis shows its mRNA vaccine candidate is more than 90% effective.
